Not the correct forum perhaps, but for those into biotech, do yourselves a favour and check the various announcements made by DNA - Ginkgo Bioworks last night.
Their results come out after hours US time today and I suspect they will not be great, but these guys are building a juggernaut bringing biotech and AI together. Just teamed up with 25 other players, and bought three other companies. X has lit up like a Christmas tree after the announcements
Their Chairman is CTO of Palantir, probably the most prominent AI company in the US. Ginkgo have recently had US senators tour their facilities and funding for national security reasons is likely a real possibility down the line.
Early stages for this one after a massively overpriced SPAC to list years ago has seen SP decimated, but that should be no reason to not consider the Company now and where the SP is now. The opportunity to unlock drug development potential and genomic sequencing is astounding. Effectively an R&D as a service, with shared financial rewards with partners
Anyway, just putting it out there for anyone interested.........
